Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Washington Prime Group Inc is a reit-retail business based in the US. Washington Prime Group shares (WPG) are listed on the NYSE and all prices are listed in US Dollars. Washington Prime Group employs 717 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.81|
|52-week range||$0.74 - $16.55|
|50-day moving average||$1.11|
|200-day moving average||$2.01|
|Wall St. target price||$3.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-15.83|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-06)||N/A|
|1 month (2021-09-17)||-23.90%|
|3 months (2021-07-16)||-58.20%|
|6 months (2021-04-16)||-63.16%|
|1 year (2020-10-16)||33.01%|
|2 years (2019-10-16)||-80.32%|
|3 years (2018-10-16)||6.49|
|5 years (2016-10-14)||11.58|
Valuing Washington Prime Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Washington Prime Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Washington Prime Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $231.5 million.
The EBITDA is a measure of a Washington Prime Group's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$543.4 million|
|Operating margin TTM||6.72%|
|Gross profit TTM||$307.5 million|
|Return on assets TTM||0.55%|
|Return on equity TTM||-55.02%|
|Market capitalisation||$20.4 million|
TTM: trailing 12 months
There are currently 3.3 million Washington Prime Group shares held short by investors – that's known as Washington Prime Group's "short interest". This figure is 16.3% down from 4.0 million last month.
There are a few different ways that this level of interest in shorting Washington Prime Group shares can be evaluated.
Washington Prime Group's "short interest ratio" (SIR) is the quantity of Washington Prime Group shares currently shorted divided by the average quantity of Washington Prime Group shares traded daily (recently around 3.6 million). Washington Prime Group's SIR currently stands at 0.93. In other words for every 100,000 Washington Prime Group shares traded daily on the market, roughly 930 shares are currently held short.
However Washington Prime Group's short interest can also be evaluated against the total number of Washington Prime Group shares, or, against the total number of tradable Washington Prime Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Washington Prime Group's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Washington Prime Group shares in existence, roughly 140 shares are currently held short) or 0.1373% of the tradable shares (for every 100,000 tradable Washington Prime Group shares, roughly 137 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Washington Prime Group.
Find out more about how you can short Washington Prime Group stock.
We're not expecting Washington Prime Group to pay a dividend over the next 12 months.
Washington Prime Group's shares were split on a 1:9 basis on 21 December 2020. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Washington Prime Group shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Washington Prime Group shares which in turn could have impacted Washington Prime Group's share price.
Over the last 12 months, Washington Prime Group's shares have ranged in value from as little as $0.74 up to $16.5499. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Washington Prime Group's is 1.4585. This would suggest that Washington Prime Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Washington Prime Group Inc. is a retail REIT and a recognized leader in the ownership, management, acquisition and development of retail properties. The Company combines a national real estate portfolio with its expertise across the entire shopping center sector to increase cash flow through rigorous management of assets and provide new opportunities to retailers looking for growth throughout the U. S. Washington Prime Group® is a registered trademark of the Company. On June 13, 2021, Washington Prime Group Inc. , along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.